Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-Resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society
06. Dezember 2024 12:00 ET
|
Neurona Therapeutics
Neurona Therapeutics Presents Positive Clinical Update:
New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meet
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
27. September 2024 14:00 ET
|
Neurona Therapeutics
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
10. September 2024 16:05 ET
|
Neurona Therapeutics
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
26. Juni 2024 16:05 ET
|
Neurona Therapeutics
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
11. Juni 2024 16:05 ET
|
Neurona Therapeutics
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
28. Mai 2024 08:00 ET
|
Neurona Therapeutics
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference